2024
Integrating 4 methods to evaluate physical function in patients with cancer (In4M): protocol for a prospective cohort study
Thanarajasingam G, Kluetz P, Bhatnagar V, Brown A, Cathcart-Rake E, Diamond M, Faust L, Fiero M, Huntington S, Jeffery M, Jones L, Noble B, Paludo J, Powers B, Ross J, Ritchie J, Ruddy K, Schellhorn S, Tarver M, Dueck A, Gross C. Integrating 4 methods to evaluate physical function in patients with cancer (In4M): protocol for a prospective cohort study. BMJ Open 2024, 14: e074030. PMID: 38199641, PMCID: PMC10806877, DOI: 10.1136/bmjopen-2023-074030.Peer-Reviewed Original ResearchConceptsPhysical function assessmentPhysical functionFunctional assessmentEvaluation of physical functionElectronic health record dataEvaluate physical functionHealth record dataSpanish-speaking patientsDigital health technologiesBreast cancerProspective cohort studyClinician-reported outcomesCancer clinical trialsClinical decision-makingStudy questionnairePatient-centred evaluationHealth technologiesMeasure symptomsOncology practiceCohort studyRecord dataPatient's impressionMayo ClinicEnglish-speakingWearable sensors
2023
Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata
Ko J, Mayo T, Bergfeld W, Dutronc Y, Yu G, Ball S, Somani N, Craiglow B. Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata. JAMA Dermatology 2023, 159: 970-976. PMID: 37556146, PMCID: PMC10413213, DOI: 10.1001/jamadermatol.2023.2581.Peer-Reviewed Original ResearchConceptsSevere alopecia areataSALT scoreAlopecia areataWeek 76Response rateWeek 52Week 36Pooled analysisHair lossLong-term extension dataEyebrow hair lossProportion of patientsWeeks of therapyClinician-reported outcomesHigh response rateHair loss scoreSelective JanusAdult patientsClinical outcomesOutcome scoresHair regrowthClinical trialsMAIN OUTCOMETreatment doseBaricitinib
2003
Guideline Recommendations for Treatment of Schizophrenia: The Impact of Managed Care
Dickey B, Normand SL, Hermann RC, Eisen SV, Cortes DE, Cleary PD, Ware N. Guideline Recommendations for Treatment of Schizophrenia: The Impact of Managed Care. JAMA Psychiatry 2003, 60: 340-348. PMID: 12695310, DOI: 10.1001/archpsyc.60.4.340.Peer-Reviewed Original ResearchMeSH KeywordsAdultAmbulatory CareAttitude to HealthFee-for-Service PlansFemaleFollow-Up StudiesGuideline AdherenceHealth Services ResearchHospitalizationHumansMaleManaged Care ProgramsMedicaidMedicareMiddle AgedOutcome Assessment, Health CarePersonal SatisfactionPractice Guidelines as TopicProspective StudiesQuality of LifeSchizophreniaConceptsTreatment of schizophreniaTreatment guidelinesMedicaid beneficiariesSchizophrenia Patient Outcomes Research Team (PORT) treatment recommendationsOutpatient mental health facilitiesDisabled Medicaid beneficiariesProspective observational studyHealth-related qualityHigh-risk adultsAdult Medicaid beneficiariesOutpatient medical recordsMain outcome measuresSchizophrenia treatment guidelinesClinician-reported outcomesWay mental health careMental health careSelf-reported qualityBehavioral health care organizationsMental health facilitiesDelivery of treatmentMental health benefitsClinical outcomesGuideline recommendationsOutpatient treatmentMedical records
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply